A multi-institutional study to assess adherence to lung stereotactic body radiotherapy planning goals

被引:6
|
作者
Woerner, Andrew [1 ]
Roeske, John C. [1 ]
Harkenrider, Matthew M. [1 ]
Fan, John [2 ]
Aydogan, Bulent [3 ]
Koshy, Matthew [3 ]
Laureckas, Robert [4 ]
Vali, Faisal [4 ]
Campana, Maria [1 ]
Surucu, Murat [1 ]
机构
[1] Loyola Univ, Med Ctr, Maywood, IL 60153 USA
[2] Edward Canc Ctr, Naperville, IL 60540 USA
[3] Univ Illinois, Dept Radiat Oncol, Chicago, IL 60612 USA
[4] Advocate Christ Med Ctr, Oak Lawn, IL 60453 USA
关键词
stereotactic body radiotherapy; SBRT; SABR; lung cancer; conformality; THERAPY ONCOLOGY GROUP; RADIATION-THERAPY; RESECTION; OUTCOMES;
D O I
10.1118/1.4926551
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: A multi-institutional planning study was performed to evaluate the frequency that current guidelines established by Radiation Therapy Oncology Group (RTOG) protocols and other literature for lung stereotactic body radiotherapy (SBRT) treatments are followed. Methods: A total of 300 patients receiving lung SBRT treatments in four different institutions were retrospectively reviewed. The treatments were delivered using Linac based SBRT (160 patients) or image guided robotic radiosurgery (140). Most tumors were located peripherally (250/300). Median fractional doses and ranges were 18 Gy (8-20 Gy), 12 Gy (6-15 Gy), and 10 Gy (5-12 Gy) for three, four, and five fraction treatments, respectively. The following planning criteria derived from RTOG trials and the literature were used to evaluate the treatment plans: planning target volumes, PTVV100 >= 95% and PTVV95 >= 99%; conformality indices, CI100% < 1.2 and CI50% range of 2.9-5.9 dependent on PTV; total lung-ITV: V-20Gy < 10%, V-12.5Gy < 15%, and V-5Gy < 37%; contralateral lung V-5Gy < 26%; and maximum doses for spinal cord, esophagus, trachea/bronchus, and heart and great vessels. Populations were grouped by number of fractions, and dosimetric criteria satisfaction rates (CSRs) were reported. Results: Five fraction regimens were the most common lung SBRT fractionation (46%). The median PTV was 27.2 cm(3) (range: 3.8-419.5 cm(3)). For all plans: mean PTVV100 was 94.5% (+/- 5.6%, planning CSR: 69.8%), mean PTVV95 was 98.1% (+/- 4.1%, CSR: 69.5%), mean CI100% was 1.14 (+/- 0.21, CSR: 79.1%, and 16.5% within minor deviation), and mean CI50% was 5.63 (+/- 2.8, CSR: 33.0%, and 28.0% within minor deviation). When comparing plans based on location, peripherally located tumors displayed higher PTVV100 and PTVV95 CSR (71.5% and 71.9%, respectively) than centrally located tumors (61.2% and 57.1%, respectively). Overall, the planning criteria were met for all the critical structure such as lung, heart, spinal cord, esophagus, and trachea/bronchus for at least 85% of the patients. Conclusions: Among the various parameters that were used to evaluate the SBRT plans, the CI100% and CI50% were the most challenging criteria to meet. Although the CSRs of organs at risk were higher among all cases, their proximity to the PTV was a significant factor. (C) 2015 American Association of Physicists in Medicine.
引用
收藏
页码:4629 / 4635
页数:7
相关论文
共 50 条
  • [1] A Multi-institutional Study to Assess Adherence to Lung Stereotactic Body Radiation Therapy Planning Goals
    Woerner, A.
    Roeske, J. C.
    Harkenrider, M. M.
    Fan, J.
    Aydogan, B.
    Koshy, M.
    Laureckas, R.
    Vali, F. S.
    Surucu, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S85 - S85
  • [2] An international multi-institutional planning study for spine stereotactic body radiotherapy
    Hiroshi, T.
    Furuya, T.
    Naoto, S.
    Nakayama, M.
    Mark, R.
    Hao, P. Jun
    Thibault, I.
    St-Hilaire, J.
    Lijun, M.
    Pinnaduwage, D.
    Sahgal, A.
    Katsuyuki, K.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S926 - S926
  • [3] Lung stereotactic ablative body radiotherapy: A large scale multi-institutional planning comparison for interpreting results of multi-institutional studies
    Giglioli, Francesca Romana
    Strigari, Lidia
    Ragona, Riccardo
    Borzi, Giuseppina R.
    Cagni, Elisabetta
    Carbonini, Claudia
    Clemente, Stefania
    Consorti, Rita
    El Gawhary, Randa
    Esposito, Marco
    Falco, Maria Daniela
    Fedele, David
    Fiandra, Christian
    Frassanito, Maria Cristina
    Landoni, Valeria
    Loi, Gianfranco
    Lorenzini, Elena
    Malisan, Maria Rosa
    Marino, Carmelo
    Menghi, Enrico
    Nardiello, Barbara
    Nigro, Roberta
    Oliviero, Caterina
    Pastore, Gabriella
    Quattrocchi, Mariagrazia
    Ruggieri, Ruggero
    Redaelli, Irene
    Reggiori, Giacomo
    Russo, Serenella
    Villaggi, Elena
    Casati, Marta
    Mancosu, Pietro
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2016, 32 (04): : 600 - 606
  • [4] Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
    Takahisa Eriguchi
    Atsuya Takeda
    Yohei Oku
    Satoshi Ishikura
    Tomoki Kimura
    Shuichi Ozawa
    Takeo Nakashima
    Yukinori Matsuo
    Mitsuhiro Nakamura
    Yasuo Matsumoto
    Sadanori Yamazaki
    Naoko Sanuki
    Yoshinori Ito
    Radiation Oncology, 8
  • [5] Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study
    Eriguchi, Takahisa
    Takeda, Atsuya
    Oku, Yohei
    Ishikura, Satoshi
    Kimura, Tomoki
    Ozawa, Shuichi
    Nakashima, Takeo
    Matsuo, Yukinori
    Nakamura, Mitsuhiro
    Matsumoto, Yasuo
    Yamazaki, Sadanori
    Sanuki, Naoko
    Ito, Yoshinori
    RADIATION ONCOLOGY, 2013, 8
  • [6] Dose prescription and reporting in stereotactic body radiotherapy: A multi-institutional study
    Das, Indra J.
    Yadav, Poonam
    Andersen, Aaron D.
    Chen, Zhe Jay
    Huang, Long
    Langer, Mark P.
    Lee, Choonik
    Li, Lin
    Popple, Richard A.
    Rice, Roger K.
    Schiff, Peter B.
    Zhu, Timothy C.
    Abazeed, Mohamed E.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182
  • [7] Evaluating dosimetric differences in spine stereotactic body radiotherapy: An international multi-institutional treatment planning study
    Furuya, Tomohisa
    Tanaka, Hiroshi
    Ruschin, Mark
    Nihei, Keiji
    Pinnaduwage, Dilini
    Ma, Lijun
    Sahgal, Arjun
    Karasawa, Katsuyuki
    JOURNAL OF RADIOSURGERY AND SBRT, 2015, 3 (04): : 307 - 314
  • [8] -1407 Multi-institutional planning study for spine stereotactic body radiation therapy with cyberknife in Japan
    Tanaka, H.
    Furuya, T.
    Nihei, K.
    Karasawa, K.
    Shikama, N.
    Kumazaki, Y.
    Miyaura, K.
    Mayahara, H.
    Nishimura, H.
    Nakayama, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S124 - S124
  • [9] Long-Term Results of a Multi-Institutional Study of Dynamic Tumor Tracking-Stereotactic Body Radiotherapy for Lung Tumors
    Matsuo, Y.
    Murofushi, K.
    Kokubo, M.
    Sakamoto, T.
    Morita, S.
    Hiraoka, M.
    Nakamura, M.
    Mizowaki, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S31 - S31
  • [10] Multi-institutional phase II study on the safety and efficacy of dynamic tumor tracking-stereotactic body radiotherapy for lung tumors
    Matsuo, Yukinori
    Hiraoka, Masahiro
    Karasawa, Katsuyuki
    Kokubo, Masaki
    Sakamoto, Takashi
    Mukumoto, Nobutaka
    Nakamura, Mitsuhiro
    Morita, Satoshi
    Mizowaki, Takashi
    RADIOTHERAPY AND ONCOLOGY, 2022, 172 : 18 - 22